Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Israel Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20071
20081
20092
20132
20152
20163
20195
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Theravance Biopharma3
Intec Pharma Ltd.2
Kyowa Kirin Co., Ltd.2
NeuroDerm Ltd.2
Solvay Pharmaceuticals2
AbbVie (prior sponsor, Abbott)1
Acorda Therapeutics1
Eisai Limited1
Newron Pharmaceuticals SPA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease22
Parkinsonian Disorders5
Dyskinesias4
Brain Diseases3
Central Nervous System Diseases3
Dizziness3
Hypotension3
Movement Disorders3
Nervous System Diseases3
Neurodegenerative Diseases3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.